J U Adelman
Overview
Explore the profile of J U Adelman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lipton R, Dodick D, Adelman J, Kaniecki R, Lener S, White J, et al.
Cephalalgia
. 2009 Feb;
29(8):826-36.
PMID: 19220307
Two identical randomized, placebo-controlled, crossover studies were conducted to evaluate consistency of response to sumatriptan/naproxen sodium 85/500 mg (S/NS) over four attacks in adults with migraine. Patients were instructed to...
2.
Adelman J, Lewit E
Clin Cornerstone
. 2003 May;
4(3):53-64.
PMID: 12739316
Triptans, beginning with sumatriptan, have revolutionized the treatment of migraine. New triptans in several formulations will soon become available in the United States. Although the similarities of these 5-hydroxytryptamine (5-HT)...
3.
Adelman J, Lipton R, Ferrari M, Diener H, McCarroll K, Vandormael K, et al.
Neurology
. 2001 Oct;
57(8):1377-83.
PMID: 11673575
Objective: To compare the efficacy of oral rizatriptan 10 mg with oral doses of sumatriptan, naratriptan, and zolmitriptan on stringent outcome measures. Methods: Retrospective analysis of data from five randomized,...
4.
Adelman J, Adelman R
Clin Ther
. 2001 Jul;
23(6):772-88; discussion 771.
PMID: 11440281
Background: Migraine is a common condition affecting approximately 18% of women and 6% of men in the United States. The goals of managing migraine are 2-fold: to prevent attacks from...
5.
Adelman J
Headache
. 2001 Jun;
38(8):621-3.
PMID: 11398307
A 21-year-old developed progressive headaches and pulsatile tinnitus. He was found to have papilledema and a pulsatile bruit. A dural arteriovenous malformation was not recognized on brain CT or MRI,...
6.
Young W, Mannix L, Adelman J, Shechter A
Headache
. 2000 Aug;
40(7):587-91.
PMID: 10940098
Objective: To describe current practice in triptan use. Background: Triptans are effective migraine treatments that cause chest symptoms in some patients. True cardiac ischemia is rare. Design.-Headache specialists and family...
7.
Adelman L, Adelman J, Von Seggern R, Mannix L
Headache
. 2000 Aug;
40(7):572-80.
PMID: 10940096
Objective: To assess the efficacy of extended-release venlafaxine in the prophylaxis of migraine and chronic tension-type headache. Background: Venlafaxine, a structurally novel antidepressant, is a selective serotonin-norepinephrine reuptake inhibitor. This...
8.
Adelman J, Mannix L, Von Seggern R
Headache
. 2000 Jun;
40(5):371-2.
PMID: 10849030
After taking both conventional oral rizatriptan tablets and oral disintegrating rizatriptan tablets in the treatment of migraine with or without aura, patients were permitted to select their formulation preference. All...
9.
Martin B, Pathak D, Sharfman M, Adelman J, Taylor F, Kwong W, et al.
Headache
. 2000 Apr;
40(3):204-15.
PMID: 10759923
Objective: To assess the scaling properties, reliability, and validity of the revised Migraine-Specific Quality of Life Questionnaire (MSQ) (Version 2.1) Background: The MSQ is a disease-specific, quality-of-life instrument with three...
10.
Adelman J, Brod A, Von Seggern R, Mannix L, Rapoport A
Cephalalgia
. 1999 Jan;
18(9):605-11.
PMID: 9876883
Newer acute care migraine medications demonstrate improved rapidity of action, consistent effectiveness, excellent safety profiles, and rarely cause rebound headaches. Their use could decrease the need for migraine-preventive medication. The...